Leonard JP[au] - PubMed - NCBI
Search: Leonard JP[au]
Select item 30248164 1.
DLBCL Cell of Origin: What Role Should It Play in Care Today?
Rutherford SC, Leonard JP.
Oncology (Williston Park). 2018 Sep 15;32(9):445-9. Review.
30248164
Select item 30181173 2.
Ruan J, Martin P, Christos P, Cerchietti L, Tam W, Shah B, Schuster SJ, Rodriguez A, Hyman D, Calvo-Vidal MN, Smith SM, Svoboda J, Furman RR, Coleman M, Leonard JP.
Blood. 2018 Nov 8;132(19):2016-2025. doi: 10.1182/blood-2018-07-859769. Epub 2018 Sep 4.
30181173
Select item 30049811 3.
Select item 30003234 4.
Management of Relapsed and Refractory Hodgkin Lymphoma in 2018.
JAMA Oncol. 2018 Aug 1;4(8):1120-1121. doi: 10.1001/jamaoncol.2018.1767. No abstract available.
30003234
Select item 29934343 5.
Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis.
Yamshon S, Christos PJ, Demetres M, Hammad H, Leonard JP, Ruan J.
Blood Adv. 2018 Jun 26;2(12):1429-1438. doi: 10.1182/bloodadvances.2018016683.
Select item 29854228 6.
Secondary Use of Patients' Electronic Records (SUPER): An Approach for Meeting Specific Data Needs of Clinical and Translational Researchers.
Sholle ET, Kabariti J, Johnson SB, Leonard JP, Pathak J, Varughese VI, Cole CL, Campion TR Jr.
AMIA Annu Symp Proc. 2018 Apr 16;2017:1581-1588. eCollection 2017.
29854228
Select item 29757375 7.
Establishing the Feasibility of a Tablet-Based Consent Process with Older Adults: A Mixed-Methods Study.
Jayasinghe N, Isabel Moallem B, Kakoullis M, Ojie MJ, Sar-Graycar L, Wyka K, Reid MC, Leonard JP.
Gerontologist. 2018 May 11. doi: 10.1093/geront/gny045. [Epub ahead of print]
29757375
Select item 29673807 8.
J Geriatr Oncol. 2018 Jul;9(4):321-328. doi: 10.1016/j.jgo.2018.03.018. Epub 2018 Apr 17.
Select item 29641966 9.
Select item 29472351 10.
Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort.
Rimsza LM, Li H, Braziel RM, Spier CM, Persky DO, Dunlap J, LeBlanc M, Bartlett N, Leonard JP, Smith SM, Press OW, Friedberg JW.
Haematologica. 2018 Apr;103(4):e151-e153. doi: 10.3324/haematol.2017.175059. Epub 2018 Feb 22. No abstract available.
29472351
Select item 29390097 11.
Ann Oncol. 2018 Jan 29. doi: 10.1093/annonc/mdx812. [Epub ahead of print] No abstract available.
Select item 29377067 12.
Bone marrow biopsies not indicated for response assessment in follicular lymphoma trials regardless of type of imaging study - Response to Adams and Kwee.
Br J Haematol. 2018 Jan 29. doi: 10.1111/bjh.15113. [Epub ahead of print] No abstract available.
29377067
Select item 29356608 13.
Select item 29265185 14.
A retrospective study of R-DHAP/Ox for early progressing follicular lymphoma.
Ghione P, Cavallo F, Visco C, Chen Z, Castellino A, Tisi MC, Dogliotti I, Nicolosi M, Boccadoro M, Leonard JP, Vitolo U, Martin P.
Br J Haematol. 2017 Dec 19. doi: 10.1111/bjh.15057. [Epub ahead of print] No abstract available.
29265185
Select item 29082519 15.
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.
Giulino-Roth L, O'Donohue T, Chen Z, Bartlett NL, LaCasce A, Martin-Doyle W, Barth MJ, Davies K, Blum KA, Christian B, Casulo C, Smith SM, Godfrey J, Termuhlen A, Oberley MJ, Alexander S, Weitzman S, Appel B, Mizukawa B, Svoboda J, Afify Z, Pauly M, Dave H, Gardner R, Stephens DM, Zeitler WA, Forlenza C, Levine J, Williams ME, Sima JL, Bollard CM, Leonard JP.
Br J Haematol. 2017 Dec;179(5):739-747. doi: 10.1111/bjh.14951. Epub 2017 Oct 29.
29082519
Select item 29051150 16.
Lymphoma "benchmark" or "bench-smudge"?
Blood. 2017 Oct 19;130(16):1778-1779. doi: 10.1182/blood-2017-08-800730. No abstract available.
29051150
Select item 28945884 17.
Select item 28899853 18.
The potential for chemotherapy-free strategies in mantle cell lymphoma.
Martin P, Ruan J, Leonard JP.
Blood. 2017 Oct 26;130(17):1881-1888. doi: 10.1182/blood-2017-05-737510. Epub 2017 Sep 12. Review.
28899853
Select item 28862883 19.
Select item 28677889 20.
Bone marrow biopsies do not impact response assessment for follicular lymphoma patients treated on clinical trials.
Rutherford SC, Li V, Ghione P, Chen Z, Martin P, Leonard JP.
Br J Haematol. 2017 Oct;179(2):242-245. doi: 10.1111/bjh.14839. Epub 2017 Jul 5.
28677889
Select item 28654364 21.
Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia.
Leonard JP, Martin P, Roboz GJ.
J Clin Oncol. 2017 Aug 10;35(23):2708-2715. doi: 10.1200/JCO.2017.72.6745. Epub 2017 Jun 27. Review.
28654364
Select item 28573908 22.
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data<sup/>.
Rutherford SC, Stewart EN, Chen Z, Chadburn A, Wehrli NE, van Besien K, Martin P, Furman RR, Leonard JP, Cerchietti L.
Leuk Lymphoma. 2018 Jan;59(1):256-258. doi: 10.1080/10428194.2017.1323270. Epub 2017 Jun 2. No abstract available.
28573908
Select item 28516440 23.
The Uncertainties of Rituximab and Related Therapies, 20 Years After Approval.
Oncology (Williston Park). 2017 May 15;31(5):412, 414. No abstract available.
28516440
Select item 28419413 24.
Select item 28379322 25.
Select item 28314699 26.
Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials.
Smith SM, Pitcher BN, Jung SH, Bartlett NL, Wagner-Johnston N, Park SI, Richards KL, Cashen AF, Jaslowski A, Smith SE, Cheson BD, Hsi E, Leonard JP.
Lancet Haematol. 2017 Apr;4(4):e176-e182. doi: 10.1016/S2352-3026(17)30028-5. Epub 2017 Mar 15.
28314699
Select item 28232365 27.
BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells.
Valls E, Lobry C, Geng H, Wang L, Cardenas M, Rivas M, Cerchietti L, Oh P, Yang SN, Oswald E, Graham CW, Jiang Y, Hatzi K, Agirre X, Perkey E, Li Z, Tam W, Bhatt K, Leonard JP, Zweidler-McKay PA, Maillard I, Elemento O, Ci W, Aifantis I, Melnick A.
Cancer Discov. 2017 May;7(5):506-521. doi: 10.1158/2159-8290.CD-16-1189. Epub 2017 Feb 23.
28232365
Select item 28040733 28.
Spurgeon SE, Till BG, Martin P, Goy AH, Dreyling MP, Gopal AK, LeBlanc M, Leonard JP, Friedberg JW, Baizer L, Little RF, Kahl BS, Smith MR.
J Natl Cancer Inst. 2016 Dec 31;109(1). pii: djw263. doi: 10.1093/jnci/djw263. Print 2017 Jan. Review.
Select item 28040700 29.
Diefenbach CS, Connors JM, Friedberg JW, Leonard JP, Kahl BS, Little RF, Baizer L, Evens AM, Hoppe RT, Kelly KM, Persky DO, Younes A, Kostakaglu L, Bartlett NL.
J Natl Cancer Inst. 2016 Dec 31;109(4). doi: 10.1093/jnci/djw249. Print 2017 Apr. Review.
Select item 28040699 30.
Maddocks K, Barr PM, Cheson BD, Little RF, Baizer L, Kahl BS, Leonard JP, Fowler N, Gordon LI, Link BK, Friedberg JW, Ansell SM.
J Natl Cancer Inst. 2016 Dec 31;109(3). doi: 10.1093/jnci/djw255. Print 2017 Mar. Review.
Select item 28040682 31.
Casulo C, O'Connor O, Shustov A, Fanale M, Friedberg JW, Leonard JP, Kahl BS, Little RF, Pinter-Brown L, Advani R, Horwitz S.
J Natl Cancer Inst. 2016 Dec 31;109(2). doi: 10.1093/jnci/djw248. Print 2017 Feb. Review.
Select item 27992063 32.
Chen RW, Li H, Bernstein SH, Kahwash S, Rimsza LM, Forman SJ, Constine L, Shea TC, Cashen AF, Blum KA, Fenske TS, Barr PM, Phillips T, Leblanc M, Fisher RI, Cheson BD, Smith SM, Faham M, Wilkins J, Leonard JP, Kahl BS, Friedberg JW.
Br J Haematol. 2017 Mar;176(5):759-769. doi: 10.1111/bjh.14480. Epub 2016 Dec 19.
Select item 27986884 33.
Select item 27986882 34.
General Biomarker Recommendations for Lymphoma.
Rimsza L, Fedoriw Y, Staudt LM, Melnick A, Gascoyne R, Crump M, Baizer L, Fu K, Hsi E, Chan JW, McShane L, Leonard JP, Kahl BS, Little RF, Friedberg JW, Kostakoglu L.
J Natl Cancer Inst. 2016 Dec 16;108(12). pii: djw250. Print 2016 Dec.
27986882
Select item 27914971 35.
Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study.
Furman RR, Eradat HA, DiRienzo CG, Hofmeister CC, Hayman SR, Leonard JP, Coleman M, Advani R, Chanan-Khan A, Switzky J, Liao QM, Shah D, Jewell RC, Lisby S, Lin TS.
Lancet Haematol. 2017 Jan;4(1):e24-e34. doi: 10.1016/S2352-3026(16)30166-1. Epub 2016 Dec 1.
27914971
Select item 29296805 36.
Select item 27697771 37.
Select item 27482887 38.
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma.
Cardenas MG, Yu W, Beguelin W, Teater MR, Geng H, Goldstein RL, Oswald E, Hatzi K, Yang SN, Cohen J, Shaknovich R, Vanommeslaeghe K, Cheng H, Liang D, Cho HJ, Abbott J, Tam W, Du W, Leonard JP, Elemento O, Cerchietti L, Cierpicki T, Xue F, MacKerell AD Jr, Melnick AM.
J Clin Invest. 2016 Sep 1;126(9):3351-62. doi: 10.1172/JCI85795. Epub 2016 Aug 2.
27482887
Select item 27419806 39.
Therapeutic implication of concomitant chromosomal aberrations in patients with aggressive B-cell lymphomas.
Marullo R, Rutherford SC, Leonard JP, Cerchietti L.
Cell Cycle. 2016 Sep;15(17):2241-7. doi: 10.1080/15384101.2016.1207839. Epub 2016 Jul 15.
27419806
Select item 27317637 40.
Behavioral and physiological characterization of PKC-dependent phosphorylation in the Grin2a∆PKC mouse.
Balu D, Larson JR, Schmidt JV, Wirtshafter D, Yevtodiyenko A, Leonard JP.
Brain Res. 2016 Sep 1;1646:315-326. doi: 10.1016/j.brainres.2016.06.022. Epub 2016 Jun 15.
27317637
Select item 27072903 41.
Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704.
Puvvada SD, Stiff PJ, Leblanc M, Cook JR, Couban S, Leonard JP, Kahl B, Marcellus D, Shea TC, Winter JN, Li H, Rimsza LM, Friedberg JW, Smith SM.
Br J Haematol. 2016 Sep;174(5):686-91. doi: 10.1111/bjh.14100. Epub 2016 Apr 13.
27072903
Select item 27069074 42.
Select item 26948439 43.
CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease.
Marshall J, Sun Y, Bangari DS, Budman E, Park H, Nietupski JB, Allaire A, Cromwell MA, Wang B, Grabowski GA, Leonard JP, Cheng SH.
Mol Ther. 2016 Jun;24(6):1019-1029. doi: 10.1038/mt.2016.53. Epub 2016 Mar 7.
Select item 26933862 44.
Lenalidomide plus Rituximab for Mantle-Cell Lymphoma.
Ruan J, Leonard JP.
N Engl J Med. 2016 Feb 25;374(8):793. doi: 10.1056/NEJMc1515465. No abstract available.
26933862
Select item 26832194 45.
CHOP Chemotherapy Followed by Tositumomab and Iodine-131 Tositumomab for Previously Untreated Diffuse Large B-cell Lymphoma.
Leonard JP, Gregory SA, Smith H, Horner TJ, Williams VC, Giampietro P, Lin TS.
Clin Lymphoma Myeloma Leuk. 2016 Apr;16(4):191-6. doi: 10.1016/j.clml.2015.12.011. Epub 2016 Jan 4.
26832194
Select item 26796979 46.
Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma.
Tang T, Chen Z, Praditsuktavorn P, Khoo LP, Ruan J, Lim ST, Tan D, Phipps C, Lee YS, Goh YT, Hwang W, Tao M, Quek R, Farid M, Furman RR, Leonard JP, Martin P.
Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):117-21. doi: 10.1016/j.clml.2015.12.006. Epub 2015 Dec 21.
26796979
Select item 26764355 47.
Martin P, Maddocks K, Leonard JP, Ruan J, Goy A, Wagner-Johnston N, Rule S, Advani R, Iberri D, Phillips T, Spurgeon S, Kozin E, Noto K, Chen Z, Jurczak W, Auer R, Chmielowska E, Stilgenbauer S, Bloehdorn J, Portell C, Williams ME, Dreyling M, Barr PM, Chen-Kiang S, DiLiberto M, Furman RR, Blum KA.
Blood. 2016 Mar 24;127(12):1559-63. doi: 10.1182/blood-2015-10-673145. Epub 2016 Jan 13.
Select item 26708981 48.
Hepatosplenic T-Cell Lymphoma Mimicking Acute Myeloid Leukemia.
Pizzi M, Covey S, Mathew S, Liu YC, Ruan J, Leonard JP, Chadburn A.
Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):e47-50. doi: 10.1016/j.clml.2015.11.019. Epub 2015 Nov 26. No abstract available.
26708981
Select item 26548716 49.
Foraging decisions in wild versus domestic Mus musculus: What does life in the lab select for?
Troxell-Smith SM, Tutka MJ, Albergo JM, Balu D, Brown JS, Leonard JP.
Behav Processes. 2016 Jan;122:43-50. doi: 10.1016/j.beproc.2015.10.020. Epub 2015 Nov 6.
26548716
Select item 26535512 50.
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma.
Ruan J, Martin P, Shah B, Schuster SJ, Smith SM, Furman RR, Christos P, Rodriguez A, Svoboda J, Lewis J, Katz O, Coleman M, Leonard JP.
N Engl J Med. 2015 Nov 5;373(19):1835-44. doi: 10.1056/NEJMoa1505237.
26535512
Leonard JP[Author]
Leonard JP[au] - PubMed - NCBI
Search: Leonard JP[au]
Select item 30248164 1.
DLBCL Cell of Origin: What Role Should It Play in Care Today?
Rutherford SC, Leonard JP.
Oncology (Williston Park). 2018 Sep 15;32(9):445-9. Review.
30248164
Select item 30181173 2.
Ruan J, Martin P, Christos P, Cerchietti L, Tam W, Shah B, Schuster SJ, Rodriguez A, Hyman D, Calvo-Vidal MN, Smith SM, Svoboda J, Furman RR, Coleman M, Leonard JP.
Blood. 2018 Nov 8;132(19):2016-2025. doi: 10.1182/blood-2018-07-859769. Epub 2018 Sep 4.
30181173
Select item 30049811 3.
Select item 30003234 4.
Management of Relapsed and Refractory Hodgkin Lymphoma in 2018.
JAMA Oncol. 2018 Aug 1;4(8):1120-1121. doi: 10.1001/jamaoncol.2018.1767. No abstract available.
30003234
Select item 29934343 5.
Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis.
Yamshon S, Christos PJ, Demetres M, Hammad H, Leonard JP, Ruan J.
Blood Adv. 2018 Jun 26;2(12):1429-1438. doi: 10.1182/bloodadvances.2018016683.
Select item 29854228 6.
Secondary Use of Patients' Electronic Records (SUPER): An Approach for Meeting Specific Data Needs of Clinical and Translational Researchers.
Sholle ET, Kabariti J, Johnson SB, Leonard JP, Pathak J, Varughese VI, Cole CL, Campion TR Jr.
AMIA Annu Symp Proc. 2018 Apr 16;2017:1581-1588. eCollection 2017.
29854228
Select item 29757375 7.
Establishing the Feasibility of a Tablet-Based Consent Process with Older Adults: A Mixed-Methods Study.
Jayasinghe N, Isabel Moallem B, Kakoullis M, Ojie MJ, Sar-Graycar L, Wyka K, Reid MC, Leonard JP.
Gerontologist. 2018 May 11. doi: 10.1093/geront/gny045. [Epub ahead of print]
29757375
Select item 29673807 8.
J Geriatr Oncol. 2018 Jul;9(4):321-328. doi: 10.1016/j.jgo.2018.03.018. Epub 2018 Apr 17.
Select item 29641966 9.
Select item 29472351 10.
Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort.
Rimsza LM, Li H, Braziel RM, Spier CM, Persky DO, Dunlap J, LeBlanc M, Bartlett N, Leonard JP, Smith SM, Press OW, Friedberg JW.
Haematologica. 2018 Apr;103(4):e151-e153. doi: 10.3324/haematol.2017.175059. Epub 2018 Feb 22. No abstract available.
29472351
Select item 29390097 11.
Ann Oncol. 2018 Jan 29. doi: 10.1093/annonc/mdx812. [Epub ahead of print] No abstract available.
Select item 29377067 12.
Bone marrow biopsies not indicated for response assessment in follicular lymphoma trials regardless of type of imaging study - Response to Adams and Kwee.
Br J Haematol. 2018 Jan 29. doi: 10.1111/bjh.15113. [Epub ahead of print] No abstract available.
29377067
Select item 29356608 13.
Select item 29265185 14.
A retrospective study of R-DHAP/Ox for early progressing follicular lymphoma.
Ghione P, Cavallo F, Visco C, Chen Z, Castellino A, Tisi MC, Dogliotti I, Nicolosi M, Boccadoro M, Leonard JP, Vitolo U, Martin P.
Br J Haematol. 2017 Dec 19. doi: 10.1111/bjh.15057. [Epub ahead of print] No abstract available.
29265185
Select item 29082519 15.
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.
Giulino-Roth L, O'Donohue T, Chen Z, Bartlett NL, LaCasce A, Martin-Doyle W, Barth MJ, Davies K, Blum KA, Christian B, Casulo C, Smith SM, Godfrey J, Termuhlen A, Oberley MJ, Alexander S, Weitzman S, Appel B, Mizukawa B, Svoboda J, Afify Z, Pauly M, Dave H, Gardner R, Stephens DM, Zeitler WA, Forlenza C, Levine J, Williams ME, Sima JL, Bollard CM, Leonard JP.
Br J Haematol. 2017 Dec;179(5):739-747. doi: 10.1111/bjh.14951. Epub 2017 Oct 29.
29082519
Select item 29051150 16.
Lymphoma "benchmark" or "bench-smudge"?
Blood. 2017 Oct 19;130(16):1778-1779. doi: 10.1182/blood-2017-08-800730. No abstract available.
29051150
Select item 28945884 17.
Select item 28899853 18.
The potential for chemotherapy-free strategies in mantle cell lymphoma.
Martin P, Ruan J, Leonard JP.
Blood. 2017 Oct 26;130(17):1881-1888. doi: 10.1182/blood-2017-05-737510. Epub 2017 Sep 12. Review.
28899853
Select item 28862883 19.
Select item 28677889 20.
Bone marrow biopsies do not impact response assessment for follicular lymphoma patients treated on clinical trials.
Rutherford SC, Li V, Ghione P, Chen Z, Martin P, Leonard JP.
Br J Haematol. 2017 Oct;179(2):242-245. doi: 10.1111/bjh.14839. Epub 2017 Jul 5.
28677889
Select item 28654364 21.
Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia.
Leonard JP, Martin P, Roboz GJ.
J Clin Oncol. 2017 Aug 10;35(23):2708-2715. doi: 10.1200/JCO.2017.72.6745. Epub 2017 Jun 27. Review.
28654364
Select item 28573908 22.
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data<sup/>.
Rutherford SC, Stewart EN, Chen Z, Chadburn A, Wehrli NE, van Besien K, Martin P, Furman RR, Leonard JP, Cerchietti L.
Leuk Lymphoma. 2018 Jan;59(1):256-258. doi: 10.1080/10428194.2017.1323270. Epub 2017 Jun 2. No abstract available.
28573908
Select item 28516440 23.
The Uncertainties of Rituximab and Related Therapies, 20 Years After Approval.
Oncology (Williston Park). 2017 May 15;31(5):412, 414. No abstract available.
28516440
Select item 28419413 24.
Select item 28379322 25.
Select item 28314699 26.
Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials.
Smith SM, Pitcher BN, Jung SH, Bartlett NL, Wagner-Johnston N, Park SI, Richards KL, Cashen AF, Jaslowski A, Smith SE, Cheson BD, Hsi E, Leonard JP.
Lancet Haematol. 2017 Apr;4(4):e176-e182. doi: 10.1016/S2352-3026(17)30028-5. Epub 2017 Mar 15.
28314699
Select item 28232365 27.
BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells.
Valls E, Lobry C, Geng H, Wang L, Cardenas M, Rivas M, Cerchietti L, Oh P, Yang SN, Oswald E, Graham CW, Jiang Y, Hatzi K, Agirre X, Perkey E, Li Z, Tam W, Bhatt K, Leonard JP, Zweidler-McKay PA, Maillard I, Elemento O, Ci W, Aifantis I, Melnick A.
Cancer Discov. 2017 May;7(5):506-521. doi: 10.1158/2159-8290.CD-16-1189. Epub 2017 Feb 23.
28232365
Select item 28040733 28.
Spurgeon SE, Till BG, Martin P, Goy AH, Dre
yling MP, Gopal AK, LeBlanc M, Leonard JP, Friedberg JW, Baizer L, Little RF, Kahl BS, Smith MR.
J Natl Cancer Inst. 2016 Dec 31;109(1). pii: djw263. doi: 10.1093/jnci/djw263. Print 2017 Jan. Review.
Select item 28040700 29.
Diefenbach CS, Connors JM, Friedberg JW, Leonard JP, Kahl BS, Little RF, Baizer L, Evens AM, Hoppe RT, Kelly KM, Persky DO, Younes A, Kostakaglu L, Bartlett NL.
J Natl Cancer Inst. 2016 Dec 31;109(4). doi: 10.1093/jnci/djw249. Print 2017 Apr. Review.
Select item 28040699 30.
Maddocks K, Barr PM, Cheson BD, Little RF, Baizer L, Kahl BS, Leonard JP, Fowler N, Gordon LI, Link BK, Friedberg JW, Ansell SM.
J Natl Cancer Inst. 2016 Dec 31;109(3). doi: 10.1093/jnci/djw255. Print 2017 Mar. Review.
Select item 28040682 31.
Casulo C, O'Connor O, Shustov A, Fanale M, Friedberg JW, Leonard JP, Kahl BS, Little RF, Pinter-Brown L, Advani R, Horwitz S.
J Natl Cancer Inst. 2016 Dec 31;109(2). doi: 10.1093/jnci/djw248. Print 2017 Feb. Review.
Select item 27992063 32.
Chen RW, Li H, Bernstein SH, Kahwash S, Rimsza LM, Forman SJ, Constine L, Shea TC, Cashen AF, Blum KA, Fenske TS, Barr PM, Phillips T, Leblanc M, Fisher RI, Cheson BD, Smith SM, Faham M, Wilkins J, Leonard JP, Kahl BS, Friedberg JW.
Br J Haematol. 2017 Mar;176(5):759-769. doi: 10.1111/bjh.14480. Epub 2016 Dec 19.
Select item 27986884 33.
Select item 27986882 34.
General Biomarker Recommendations for Lymphoma.
Rimsza L, Fedoriw Y, Staudt LM, Melnick A, Gascoyne R, Crump M, Baizer L, Fu K, Hsi E, Chan JW, McShane L, Leonard JP, Kahl BS, Little RF, Friedberg JW, Kostakoglu L.
J Natl Cancer Inst. 2016 Dec 16;108(12). pii: djw250. Print 2016 Dec.
27986882
Select item 27914971 35.
Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study.
Furman RR, Eradat HA, DiRienzo CG, Hofmeister CC, Hayman SR, Leonard JP, Coleman M, Advani R, Chanan-Khan A, Switzky J, Liao QM, Shah D, Jewell RC, Lisby S, Lin TS.
Lancet Haematol. 2017 Jan;4(1):e24-e34. doi: 10.1016/S2352-3026(16)30166-1. Epub 2016 Dec 1.
27914971
Select item 29296805 36.
Select item 27697771 37.
Select item 27482887 38.
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma.
Cardenas MG, Yu W, Beguelin W, Teater MR, Geng H, Goldstein RL, Oswald E, Hatzi K, Yang SN, Cohen J, Shaknovich R, Vanommeslaeghe K, Cheng H, Liang D, Cho HJ, Abbott J, Tam W, Du W, Leonard JP, Elemento O, Cerchietti L, Cierpicki T, Xue F, MacKerell AD Jr, Melnick AM.
J Clin Invest. 2016 Sep 1;126(9):3351-62. doi: 10.1172/JCI85795. Epub 2016 Aug 2.
27482887
Select item 27419806 39.
Therapeutic implication of concomitant chromosomal aberrations in patients with aggressive B-cell lymphomas.
Marullo R, Rutherford SC, Leonard JP, Cerchietti L.
Cell Cycle. 2016 Sep;15(17):2241-7. doi: 10.1080/15384101.2016.1207839. Epub 2016 Jul 15.
27419806
Select item 27317637 40.
Behavioral and physiological characterization of PKC-dependent phosphorylation in the Grin2a∆PKC mouse.
Balu D, Larson JR, Schmidt JV, Wirtshafter D, Yevtodiyenko A, Leonard JP.
Brain Res. 2016 Sep 1;1646:315-326. doi: 10.1016/j.brainres.2016.06.022. Epub 2016 Jun 15.
27317637
Select item 27072903 41.
Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704.
Puvvada SD, Stiff PJ, Leblanc M, Cook JR, Couban S, Leonard JP, Kahl B, Marcellus D, Shea TC, Winter JN, Li H, Rimsza LM, Friedberg JW, Smith SM.
Br J Haematol. 2016 Sep;174(5):686-91. doi: 10.1111/bjh.14100. Epub 2016 Apr 13.
27072903
Select item 27069074 42.
Select item 26948439 43.
CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease.
Marshall J, Sun Y, Bangari DS, Budman E, Park H, Nietupski JB, Allaire A, Cromwell MA, Wang B, Grabowski GA, Leonard JP, Cheng SH.
Mol Ther. 2016 Jun;24(6):1019-1029. doi: 10.1038/mt.2016.53. Epub 2016 Mar 7.
Select item 26933862 44.
Lenalidomide plus Rituximab for Mantle-Cell Lymphoma.
Ruan J, Leonard JP.
N Engl J Med. 2016 Feb 25;374(8):793. doi: 10.1056/NEJMc1515465. No abstract available.
26933862
Select item 26832194 45.
CHOP Chemotherapy Followed by Tositumomab and Iodine-131 Tositumomab for Previously Untreated Diffuse Large B-cell Lymphoma.
Leonard JP, Gregory SA, Smith H, Horner TJ, Williams VC, Giampietro P, Lin TS.
Clin Lymphoma Myeloma Leuk. 2016 Apr;16(4):191-6. doi: 10.1016/j.clml.2015.12.011. Epub 2016 Jan 4.
26832194
Select item 26796979 46.
Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma.
Tang T, Chen Z, Praditsuktavorn P, Khoo LP, Ruan J, Lim ST, Tan D, Phipps C, Lee YS, Goh YT, Hwang W, Tao M, Quek R, Farid M, Furman RR, Leonard JP, Martin P.
Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):117-21. doi: 10.1016/j.clml.2015.12.006. Epub 2015 Dec 21.
26796979
Select item 26764355 47.
Martin P, Maddocks K, Leonard JP, Ruan J, Goy A, Wagner-Johnston N, Rule S, Advani R, Iberri D, Phillips T, Spurgeon S, Kozin E, Noto K, Chen Z, Jurczak W, Auer R, Chmielowska E, Stilgenbauer S, Bloehdorn J, Portell C, Williams ME, Dreyling M, Barr PM, Chen-Kiang S, DiLiberto M, Furman RR, Blum KA.
Blood. 2016 Mar 24;127(12):1559-63. doi: 10.1182/blood-2015-10-673145. Epub 2016 Jan 13.
Select item 26708981 48.
Hepatosplenic T-Cell Lymphoma Mimicking Acute Myeloid Leukemia.
Pizzi M, Covey S, Mathew S, Liu YC, Ruan J, Leonard JP, Chadburn A.
Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):e47-50. doi: 10.1016/j.clml.2015.11.019. Epub 2015 Nov 26. No abstract available.
26708981
Select item 26548716 49.
Foraging decisions in wild versus domestic Mus musculus: What does life in the lab select for?
Troxell-Smith SM, Tutka MJ, Albergo JM, Balu D, Brown JS, Leonard JP.
Behav Processes. 2016 Jan;122:43-50. doi: 10.1016/j.beproc.2015.10.020. Epub 2015 Nov 6.
26548716
Select item 26535512 50.
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma.
Ruan J, Martin P, Shah B, Schuster SJ, Smith SM, Furman RR, Christos P, Rodriguez A, Svoboda J, Lewis J, Katz O, Coleman M, Leonard JP.
N Engl J Med. 2015 Nov 5;373(19):1835-44. doi: 10.1056/NEJMoa1505237.
26535512
Leonard JP[Author]